Are you ready to seize the moment?
Health is the biggest driver of a person’s life satisfaction: explaining 48% of life-satisfaction differences between individuals of the same age. And poor health is expensive: 63% of years lost to poor health are in the working age population. This costs the UK around £300bn in lost output annually, excluding health costs. The UK can drive economic success through the fast-growing life sciences and health sectors, with the global market in pharmaceuticals and medtech worth £1.2tn in 2020 alone.
We must strengthen focus on business-led health interventions as an essential tool to boost health and prosperity.
By increasing R&D investment in innovation and clinical trials, hitting 2.4% of GDP target by 2027, we can bring the most innovative and cost-effective health products to UK markets.
Target gaining market share in emerging areas such as genomics – where a UK competitive strength already exists.
The focus on employee health and wellbeing during the COVID-19 pandemic was admirable – but now it needs locking in.
On measures like mental wellbeing, alcohol consumption, and obesity.
In order to realise opportunities in a fast-growing, competitive global market.
Maintain high levels of public-private collaboration and agile regulation, and implement the procurement strategies to make the NHS a leader in innovative healthcare.
To reinforce UK’s position as a global hub for clinical trials, life science innovation and data driven healthcare.
By increasing focus on workplace health interventions that ensure strides made during the pandemic are not lost.